ACE and COVID-19: Another important consideration is the potential confounding effect of co-prescribed medications with reported protective properties against COVID-19 severity, such as antiplatelet agents, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, statins, metformin, fluvoxamine, fluoxetine, and aripiprazole.